MedTrace Logo

Re-Step: Dynamic Balance Treatment of Gait for Acquired Brain Injury (ABI) Victims

NCT02215590 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2021-03-12

No results posted yet for this study

Summary

The purpose of this study is to:

1. Test the walking functionality of people following Acquired brain injury (ABI)
2. Suggesting a new treatment for their walking impairments
3. Follow-up of motor learning ability and balance after intervention within this population

The investigators intend to target dynamic stability and gait after ABI, in a group of individuals with ABI who have persistent balance and mobility deficits despite being able to walk independently and having high scores on standard clinical balance measures.

Interventions: Training with Re-Step system shoes.

In this study there is no control group.

Conditions

  • Acquired Brain Injury

Interventions

DEVICE

Re-Step

Research Group: Each session begins with a warm-up exercise, muscle stretching, and strengthening exercises: duration 10 minutes. Afterwards, walking exercises for 40 minutes with Re-Step according to a program individually tailored and progressing with the training. Progress is shown by an increased range of tilting of the shoe and speed of changes, according to the individual ability of each patient. At the end of the session 10 min of cool-down exercises 22 training sessions of 60 minutes each, twice a week.

Sponsors & Collaborators

  • Reuth Rehabilitation Hospital

    lead OTHER

Principal Investigators

  • Simona Bar-Haim, PhD; PT · The Laboratory for Rehabilitation and Motor Control of Walking Faculty of Health Sciences at Ben-Gurion University of the Negev Israel

  • Jean-Jacques Vatine, Dr. · Reuth Rehabilitation Hospital Tel-Aviv Israel.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2018-05-30
Completion
2018-05-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02215590 on ClinicalTrials.gov